XPath Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Debt - Acquisition
- Financing Rounds
-
2
- Investments
-
1
XPath General Information
Description
Provider of cancer diagnosis services across France. The company specializes in anatomic-cytopathology and diagnoses any pathologies such as cancer, inflammation, infectious elements, degenerative diseases and metabolic problems.
Contact Information
Website
www.xpath.frCorporate Office
- 26 Rue Danielle Casanova
- 75002 Paris
- France
Corporate Office
- 26 Rue Danielle Casanova
- 75002 Paris
- France
XPath Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
XPath Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
XPath Investments (1)
XPath’s most recent deal was a Buyout/LBO with Sipath Unilabs. The deal was made on 18-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sipath Unilabs | 18-Sep-2026 | Buyout/LBO | Laboratory Services (Healthcare) |
XPath FAQs
-
When was XPath founded?
XPath was founded in 2019.
-
Where is XPath headquartered?
XPath is headquartered in Paris, France.
-
What industry is XPath in?
XPath’s primary industry is Clinics/Outpatient Services.
-
Is XPath a private or public company?
XPath is a Private company.
-
What is XPath’s current revenue?
The current revenue for XPath is .
-
How much funding has XPath raised over time?
XPath has raised $58M.
-
Who are XPath’s investors?
Enthéos, Parvilla Investissements, Sagesse Retraite Santé, and Techlife Capital have invested in XPath.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
